المؤلفون: Kunihiko Kobayashi, Hiromi Nagashima, Gyo Asai, Yosuke Kawashima, Shunichi Sugawara, Kana Watanabe, Naoki Furuya, Masahiro Seike, Ichiro Nakachi, Koichi Azuma, Satoshi Watanabe, Morihito Okada, Ou Yamaguchi, Yoshio Tsunezuka, Yukari Tsubata, Haruhiro Saito, Makoto Maemondo, Koichi Hagiwara, Masaki Miyazaki, Shunichiro Iwasawa, Kozo Yoshimori, Futoshi Kurimoto, Yuka Fujita, Toshihiro Nukiwa, Satoshi Morita, Tatsuro Fukuhara

المصدر: The Lancet Respiratory Medicine. 10:72-82

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, Combination therapy, Population, Disease-Free Survival, Erlotinib Hydrochloride, Japan, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lung cancer, education, education.field_of_study, business.industry, Hazard ratio, medicine.disease, Survival Analysis, ErbB Receptors, Clinical trial, Quality of Life, Erlotinib, business, Progressive disease, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e06dbd6beba5b3e41be5f0ed8a144eb5Test
https://doi.org/10.1016/s2213-2600Test(21)00166-1

المؤلفون: Shunichi Sugawara, Junji Kishimoto, Hajime Asahina, Kenji Sugio, Yukari Tsubata, Yoshihiro Miyata, Kana Watanabe, Kosuke Hamai, Taishi Harada, Takahiro Uchida, Isamu Okamoto, Satoshi Oizumi, Kentaro Tanaka, Kunihiko Kobayashi

المصدر: European Journal of Cancer. 149:14-22

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, Time Factors, Combination therapy, Pemetrexed, Carboplatin, 03 medical and health sciences, chemistry.chemical_compound, T790M, 0302 clinical medicine, Japan, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Osimertinib, Protein Kinase Inhibitors, Aged, Aged, 80 and over, Acrylamides, Aniline Compounds, business.industry, Standard treatment, Middle Aged, Progression-Free Survival, ErbB Receptors, 030104 developmental biology, chemistry, Tolerability, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e08253a3dfa77690711faf8a43d04014Test
https://doi.org/10.1016/j.ejca.2021.02.019Test

المؤلفون: Hiroyuki Yanai, Keisuke Aoe, Nobuhisa Ishikawa, Hiroshige Yoshioka, Akihiro Bessho, Toshiyuki Kozuki, Shoichi Kuyama, Seigo Miyoshi, Katsuyuki Hotta, Takuo Shibayama, Haruyuki Kawai, Kadoaki Ohashi, Yoshikazu Awaya, Hideto Obata, Kazunori Fujitaka, Masaaki Inoue, Koji Inoue, Yukari Tsubata, Naokatsu Horita, Kiichiro Ninomiya, Katsuyuki Kiura

المصدر: Lung Cancer. 150:83-89

مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Subset Analysis, Oncology, Cancer Research, medicine.medical_specialty, Lung Neoplasms, 03 medical and health sciences, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Internal medicine, Carcinoma, Humans, Medicine, Prospective Studies, Epidermal growth factor receptor, skin and connective tissue diseases, Prospective cohort study, Protein Kinase Inhibitors, neoplasms, Performance status, biology, business.industry, Standard treatment, Hazard ratio, Cancer, medicine.disease, respiratory tract diseases, ErbB Receptors, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Mutation, biology.protein, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f022ec7f30e6fca0ec7c93e85909aa9Test
https://doi.org/10.1016/j.lungcan.2020.09.024Test

المؤلفون: Yukari Tsubata, Ryosuke Tanino, Takeshi Isobe

المصدر: Cells, Vol 10, Iss 3192, p 3192 (2021)
Cells

مصطلحات موضوعية: Lung Neoplasms, QH301-705.5, medicine.medical_treatment, epidermal growth factor receptor-tyrosine kinase inhibitor, Review, Drug resistance, medicine.disease_cause, Targeted therapy, T790M, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Osimertinib, Epidermal growth factor receptor, Biology (General), Lung cancer, pemetrexed, Protein Kinase Inhibitors, Mutation, biology, business.industry, epidermal growth factor receptor gene mutation, acquired resistance, General Medicine, medicine.disease, targeted therapy, respiratory tract diseases, ErbB Receptors, Pemetrexed, Drug Resistance, Neoplasm, Cancer research, biology.protein, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b821e4a0af25a06d568ce40ffdde8aadTest
https://www.mdpi.com/2073-4409/10/11/3192Test

المؤلفون: Yukari Tsubata, Kana Watanabe, Ryota Saito, Atsushi Nakamura, Hiroshige Yoshioka, Mami Morita, Ryoichi Honda, Nobuhiro Kanaji, Satoshi Oizumi, Daisuke Jingu, Taku Nakagawa, Kensuke Nakazawa, Atsuto Mouri, Susumu Takeuchi, Naoki Furuya, Yuki Akazawa, Kiyotaka Miura, Eiki Ichihara, Makoto Maemondo, Satoshi Morita, Kunihiko Kobayashi, Takeshi Isobe

المصدر: Int J Clin Oncol

مصطلحات موضوعية: ErbB Receptors, Acrylamides, Aniline Compounds, Lung Neoplasms, Oncology, Carcinoma, Non-Small-Cell Lung, Mutation, Correction, Humans, Surgery, Hematology, General Medicine, Protein Kinase Inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7affbd4e788a39771569fd9ae2feff6eTest
https://doi.org/10.1007/s10147-022-02118-8Test

المؤلفون: Kenichiro Kudo, Kazuya Nishii, Go Makimoto, Nobuhisa Ishikawa, Yukari Tsubata, Masahiro Kodani, Nobukazu Fujimoto, Masahiro Yamasaki, Tetsuya Kubota, Nagio Takigawa, Kazunori Fujitaka, Nobuhiro Kanaji, Takuo Shibayama, Junko Itano, Chihiro Ando, Katsuyuki Hotta, Katsuyuki Kiura

المصدر: Journal of cancer research and clinical oncology. 148(8)

مصطلحات موضوعية: Cancer Research, Aniline Compounds, Lung Neoplasms, Biopsy, General Medicine, ErbB Receptors, Observational Studies as Topic, Oncology, Drug Resistance, Neoplasm, Carcinoma, Non-Small-Cell Lung, Mutation, Humans, Prospective Studies, Registries, Lung, Protein Kinase Inhibitors, Retrospective Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860f03c8b7653e03b37ee0325cae2517Test
https://pubmed.ncbi.nlm.nih.gov/35386002Test

المؤلفون: Takamasa Hotta, Shunichi Hamaguchi, Kazunori Fujitaka, Akihisa Sutani, Kosuke Hamai, Takeshi Isobe, Megumi Hamaguchi, Nobuhisa Ishikawa, Masaya Taniwaki, Yukari Tsubata, Akari Tanino, Takeshi Masuda, Masahiro Yamasaki

المصدر: Geriatrics & Gerontology International

مصطلحات موضوعية: Oncology, non‐small cell lung cancer, medicine.medical_specialty, epidermal growth factor receptor tyrosine kinase inhibitor, Lung Neoplasms, Erlotinib Hydrochloride, Gefitinib, Epidermal growth factor, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Epidermal growth factor receptor, Prospective Studies, Lung cancer, Adverse effect, Aged, biology, business.industry, Therapeutic effect, Original Articles: Epidemiology, Clinical Practice and Health, medicine.disease, older patients, Clinical trial, ErbB Receptors, quality of life, Mutation, biology.protein, Original Article, Erlotinib, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c60be000b9eaba6c4a0c5e650cbfd4dTest
https://pubmed.ncbi.nlm.nih.gov/34378299Test

المؤلفون: Kazunori Fujitaka, Yukari Tsubata, Masafumi Hongoh, Masahiro Yamasaki, Nobuhisa Ishikawa, Kosuke Hamai, Takeshi Isobe, Jun Sugisaka, Noriyuki Ishihara, Akari Tanino, Misato Kobayashi, Takamasa Hotta, Tetsuya Kubota, Atsushi Nakamura, Nobuhiro Nishimura

المصدر: Respiratory investigation. 59(3)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Male, medicine.medical_specialty, Lung Neoplasms, Pyridines, Afatinib, Antineoplastic Agents, 03 medical and health sciences, chemistry.chemical_compound, Erlotinib Hydrochloride, 0302 clinical medicine, Gefitinib, Edoxaban, Internal medicine, Carcinoma, Non-Small-Cell Lung, medicine, Humans, Drug Interactions, cardiovascular diseases, 030212 general & internal medicine, Epidermal growth factor receptor, Lung cancer, Protein Kinase Inhibitors, Aged, Aged, 80 and over, biology, business.industry, Warfarin, Cancer, Venous Thromboembolism, Middle Aged, medicine.disease, respiratory tract diseases, ErbB Receptors, Thiazoles, 030228 respiratory system, chemistry, Mutation, biology.protein, Drug Therapy, Combination, Female, Erlotinib, business, medicine.drug, Factor Xa Inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2b9b06e1d5604ecedfadda7195e690bTest
https://pubmed.ncbi.nlm.nih.gov/33386292Test

المؤلفون: Tatsuro Fukuhara, Shunichi Sugawara, Ou Yamaguchi, Toshihiro Nukiwa, Yukari Tsubata, Satoshi Watanabe, Hiromi Nagashima, Ichiro Nakachi, Yoshio Tsunezuka, Kozo Yoshimori, Koichi Hagiwara, Futoshi Kurimoto, Naoki Furuya, Shunichiro Iwasawa, Morihito Okada, Yuka Fujita, Akihiko Gemma, Kana Watanabe, Haruhiro Saito, Satoshi Morita, Gyo Asai, Masaki Miyazaki, Kunihiko Kobayashi, Koichi Azuma, Makoto Maemondo

المصدر: EBioMedicine
EBioMedicine, Vol 57, Iss, Pp 102861-(2020)

مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Research paper, Lung Neoplasms, Combination therapy, Bevacizumab, lcsh:Medicine, Phases of clinical research, General Biochemistry, Genetics and Molecular Biology, 03 medical and health sciences, T790M, Erlotinib Hydrochloride, 0302 clinical medicine, Internal medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, Protein Kinase Inhibitors, Aged, lcsh:R5-920, business.industry, lcsh:R, General Medicine, Middle Aged, medicine.disease, Progression-Free Survival, Clinical trial, ErbB Receptors, 030104 developmental biology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Mutation, Commentary, Female, Erlotinib, lcsh:Medicine (General), business, Cell-Free Nucleic Acids, Progressive disease, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330f72fcd1d7ffd69c1bc0e46ad860e7Test
http://ir.lib.shimane-u.ac.jp/52709Test

المؤلفون: Tamio Okimoto, Yukari Tsubata, Rong Sun, Takeshi Isobe, Xuexia Tong, Ryosuke Tanino, Mayumi Takechi

المصدر: Respiratory Research
Respiratory Research, Vol 20, Iss 1, Pp 1-14 (2019)

مصطلحات موضوعية: 0301 basic medicine, Lung Neoplasms, Tyrosine kinase inhibitor, Tyrosine-kinase inhibitor, Receptor tyrosine kinase, Mice, Random Allocation, 0302 clinical medicine, Reference Values, Carcinoma, Non-Small-Cell Lung, Tumor Cells, Cultured, Osimertinib, Epidermal growth factor receptor, Molecular Targeted Therapy, Phosphorylation, RNA, Small Interfering, Mice, Inbred BALB C, biology, PTK2, Protein-Tyrosine Kinases, Combined inhibition, ErbB Receptors, 030220 oncology & carcinogenesis, Female, medicine.drug_class, Cell Survival, EGFR, Hyperphosphorylation, Pemetrexed, 03 medical and health sciences, Erlotinib Hydrochloride, medicine, Animals, Humans, Lung cancer, Protein kinase B, Cell Proliferation, lcsh:RC705-779, business.industry, Research, Receptor Protein-Tyrosine Kinases, lcsh:Diseases of the respiratory system, medicine.disease, Xenograft Model Antitumor Assays, respiratory tract diseases, Disease Models, Animal, 030104 developmental biology, Drug Resistance, Neoplasm, Drug resistance, Mutation, biology.protein, Cancer research, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93f639f0b592dc6a3d04dc95a0be8439Test
http://europepmc.org/articles/PMC6889213Test